The Korea Exchange KOSDAQ Market Division announced on the 11th that a rights issue due to a free capital increase will be conducted for SLS Bio on the 12th. The reference price is 2,435 KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing